Léa Resmini
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 2
-
- Tryptophan and brain disorders 1
- Co-authors
- Christophe Battail (1 shared paper)Claire Bouvard (1 shared paper)Virginie Poindessous (1 shared paper)Agnès Desroches‐Castan (1 shared paper)Nicolas Ricard (1 shared paper)Emmanuelle Tillet (1 shared paper)Olivia Lenoir (1 shared paper)Pierre‐Louis Tharaux (2 shared papers)
- Journals
- Genome Medicine (1 paper)EClinicalMedicine (1 paper)JAMA Internal Medicine (1 paper)BMC Nephrology (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Léa Resmini
8 papers receiving 1.0k citations
Léa Resmini's Hit Papers
Peers
Comparison fields: 5 of 77
- Infectious Diseases 672
- Neurology 317
- Critical Care and Intensive Care Medicine 34
- Immunology 129
- Applied Microbiology and Biotechnology 8
Countries citing papers authored by Léa Resmini
This map shows the geographic impact of Léa Resmini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Léa Resmini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Léa Resmini more than expected).
Fields of papers citing papers by Léa Resmini
This network shows the impact of papers produced by Léa Resmini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Léa Resmini. The network helps show where Léa Resmini may publish in the future.
Co-authors
The 12 scholars most cited alongside Léa Resmini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia Hit paper breakdown → | 2020 | 589 |
| 2 | Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial Hit paper breakdown → | 2021 | 229 |
| 3 | 2022 | 142 | |
| 4 | 2023 | 56 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 3 | |
| 8 | 2024 | 2 | |
| 9 | 2025 | 0 | |
| 10 | 2026 | 0 |
About Léa Resmini
Léa Resmini is a scholar working on Infectious Diseases, Biological Psychiatry, Speech and Hearing, Genetics and Psychiatry and Mental health, having authored 10 papers that have together received 1.0k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Tryptophan and brain disorders (1 paper), Adolescent and Pediatric Healthcare (1 paper), Diabetes and associated disorders (1 paper), Bipolar Disorder and Treatment (1 paper), Vascular Anomalies and Treatments (1 paper) and Long-Term Effects of COVID-19 (1 paper). The work is most often cited by research in Infectious Diseases (672 citations), Neurology (317 citations), Critical Care and Intensive Care Medicine (34 citations), Immunology (129 citations) and Applied Microbiology and Biotechnology (8 citations). Léa Resmini has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Christophe Battail, Claire Bouvard, Virginie Poindessous, Agnès Desroches‐Castan, Nicolas Ricard, Emmanuelle Tillet, Olivia Lenoir, Pierre‐Louis Tharaux, Caroline Roelants and Julien Dang. Their work appears in journals such as Genome Medicine, EClinicalMedicine, JAMA Internal Medicine, BMC Nephrology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.